Index S&P 500 P/E 34.88 EPS (ttm) 6.69 Insider Own 0.59% Shs Outstand 72.30M Perf Week 4.05%
Market Cap 16.87B Forward P/E 32.92 EPS next Y 7.09 Insider Trans -0.16% Shs Float 71.87M Perf Month 10.58%
Income 492.70M PEG 5.73 EPS next Q 1.23 Inst Own 97.11% Short Float 1.91% Perf Quarter -29.31%
Sales 2.89B P/S 5.83 EPS this Y -9.28% Inst Trans 1.87% Short Ratio 1.47 Perf Half Y -21.38%
Book/sh 37.10 P/B 6.29 EPS next Y 15.72% ROA 13.19% Short Interest 1.37M Perf Year -39.81%
Cash/sh 6.70 P/C 34.81 EPS next 5Y 6.09% ROE 17.71% 52W Range 197.01 - 400.88 Perf YTD -28.77%
Dividend Est. 0.67 (0.29%) P/FCF 61.03 EPS past 5Y 15.84% ROI 16.60% 52W High -41.80% Beta 1.20
Dividend TTM 0.82 (0.35%) Quick Ratio 2.11 Sales past 5Y 10.11% Gross Margin 34.65% 52W Low 18.43% ATR (14) 9.05
Dividend Ex-Date Apr 30, 2025 Current Ratio 2.79 EPS Y/Y TTM -15.47% Oper. Margin 20.61% RSI (14) 42.23 Volatility 2.86% 3.58%
Employees 10600 Debt/Eq 0.11 Sales Y/Y TTM -1.93% Profit Margin 17.03% Recom 1.60 Target Price 277.67
Option/Short Yes / Yes LT Debt/Eq 0.11 EPS Q/Q -2.84% Payout 12.27% Rel Volume 0.19 Prev Close 234.47
Sales Surprise 1.12% EPS Surprise 5.87% Sales Q/Q 2.24% Earnings Feb 13 BMO Avg Volume 928.83K Price 233.32
SMA20 3.40% SMA50 -17.05% SMA200 -23.51% Trades
Volume 15,451 Change -0.49%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-18-25 Initiated Evercore ISI
Outperform
$275
Feb-14-25 Upgrade Deutsche Bank
Hold → Buy
$250
Jan-08-25 Initiated Citigroup
Buy
$400
Dec-13-24 Initiated Wolfe Research
Peer Perform
Dec-12-24 Upgrade UBS
Neutral → Buy
$350 → $390
Feb-07-24 Upgrade Jefferies
Hold → Buy
$323 → $536
Jun-16-23 Upgrade BofA Securities
Neutral → Buy
$390 → $405
Apr-11-23 Upgrade Stephens
Equal-Weight → Overweight
$330 → $400
Dec-14-22 Initiated Deutsche Bank
Hold
$250
Nov-30-22 Initiated UBS
Neutral
$250
Oct-28-22 Downgrade BofA Securities
Buy → Neutral
$385 → $250
Nov-10-20 Initiated KeyBanc Capital Markets
Overweight
$350
Oct-14-20 Initiated Stephens
Equal-Weight
$300
Jul-21-20 Upgrade BofA Securities
Neutral → Buy
$280
Apr-24-20 Upgrade BofA/Merrill
Underperform → Neutral
$145 → $200
Dec-12-19 Downgrade BofA/Merrill
Neutral → Underperform
Jul-26-19 Upgrade BofA/Merrill
Underperform → Neutral
May-01-19 Downgrade Jefferies
Buy → Hold
$122
Apr-23-19 Initiated William Blair
Outperform
Apr-25-18 Downgrade BofA/Merrill
Neutral → Underperform
Show Previous Ratings
Mar-09-25 08:51PM
Mar-05-25 06:00AM
Feb-28-25 07:21PM
Feb-20-25 04:30PM
Feb-19-25 10:36PM
09:37AM
Loading…
Feb-17-25 09:37AM
Feb-14-25 11:49AM
(Morningstar Research) +7.84%
07:51AM
02:14AM
Feb-13-25 07:22PM
(Morningstar Research) -38.22%
01:48PM
12:51PM
11:29AM
07:10AM
06:18AM
(Associated Press Finance)
06:05AM
Loading…
06:05AM
06:00AM
Feb-12-25 08:51AM
08:03AM
Jan-30-25 06:00AM
Jan-28-25 12:00PM
Jan-22-25 10:36AM
06:00AM
Jan-06-25 04:30PM
Dec-14-24 06:45AM
Dec-13-24 08:00AM
Dec-11-24 06:00AM
Dec-10-24 09:31AM
Nov-27-24 09:04AM
Nov-16-24 10:12AM
12:15PM
Loading…
Oct-30-24 12:15PM
Oct-29-24 06:00AM
Oct-26-24 01:03AM
Oct-25-24 08:16AM
03:11AM
Oct-24-24 08:50PM
(Morningstar Research) +15.43%
05:12PM
01:09PM
07:10AM
06:07AM
(Associated Press Finance)
06:00AM
Oct-22-24 12:02PM
06:00AM
Oct-17-24 10:01AM
Oct-10-24 06:00AM
Oct-09-24 06:00AM
Oct-07-24 09:54PM
06:00AM
Sep-18-24 05:15PM
Sep-05-24 06:00AM
Aug-29-24 07:06PM
(Morningstar Research) +5.77%
Aug-19-24 07:14AM
Jul-26-24 10:31AM
Jul-25-24 06:58PM
(Morningstar Research) -14.40%
09:50AM
07:10AM
06:10AM
(Associated Press Finance)
06:00AM
Jul-22-24 09:51AM
Jul-17-24 04:01AM
Jul-11-24 06:00AM
Jun-21-24 01:37PM
Jun-13-24 07:02PM
Jun-06-24 02:31PM
02:25PM
May-29-24 06:00AM
May-28-24 06:00AM
May-24-24 04:57AM
May-09-24 03:43PM
Apr-30-24 09:19AM
06:00AM
Apr-29-24 07:40PM
Apr-27-24 01:07AM
Apr-26-24 11:34AM
11:07AM
10:56AM
03:12AM
Apr-25-24 10:31AM
09:12AM
08:34AM
07:10AM
07:02AM
06:43AM
06:08AM
(Associated Press Finance)
06:00AM
Apr-24-24 12:10PM
Apr-22-24 09:44AM
Apr-18-24 10:01AM
Apr-17-24 07:44AM
Apr-11-24 06:00AM
Apr-01-24 07:36AM
Mar-14-24 04:46PM
12:07PM
Mar-13-24 07:27PM
06:57AM
Mar-12-24 03:00PM
Feb-29-24 11:31PM
Feb-28-24 04:30PM
Feb-27-24 01:01PM
Feb-23-24 12:03AM
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Birkett Bernard Sr VP, Chief Financial Officer Feb 18 '25 Option Exercise 211.00 904 190,814 7,669 Feb 20 09:44 PM Reiss-Clark Cindy Chief Commercial Officer Feb 18 '25 Option Exercise 211.00 246 51,940 5,131 Feb 20 09:16 PM MacKay Kimberly Banks SVP, GC & Corporate Secretary Feb 18 '25 Option Exercise 211.00 246 51,940 1,605 Feb 20 09:13 PM Favorite Annette F Sr. VP & Chief HR Officer Feb 18 '25 Option Exercise 211.00 246 51,940 6,823 Feb 20 09:11 PM Winters Chad VP, Chief Accounting Officer Feb 18 '25 Option Exercise 211.00 82 17,313 1,391 Feb 20 09:09 PM Witherspoon Charles VP & Treasurer Feb 18 '25 Option Exercise 211.00 66 13,864 1,319 Feb 20 09:08 PM Green Eric Mark President, CEO and Board Chair Feb 18 '25 Option Exercise 211.00 2,461 519,269 170,369 Feb 20 09:06 PM Witherspoon Charles VP & Treasurer Oct 29 '24 Option Exercise 173.22 478 82,799 1,956 Oct 31 12:05 PM Witherspoon Charles VP & Treasurer Oct 29 '24 Sale 310.40 703 218,211 1,253 Oct 31 12:05 PM Abraham Silji SVP, Chief Technology Officer Oct 29 '24 Option Exercise 0.00 458 0 3,318 Oct 31 11:50 AM Witherspoon Charles VP & Treasurer Aug 19 '24 Option Exercise 102.51 529 54,228 2,507 Aug 21 05:02 PM Witherspoon Charles VP & Treasurer Aug 19 '24 Sale 300.00 1,029 308,700 1,478 Aug 21 05:02 PM Hofmann Thomas W Director May 10 '24 Sale 365.92 617 225,773 43,565 Aug 21 04:51 PM Green Eric Mark President, CEO and Board Chair Aug 06 '24 Option Exercise 59.64 36,732 2,190,696 192,640 Aug 08 04:16 PM Green Eric Mark President, CEO and Board Chair Aug 06 '24 Sale 304.71 30,732 9,364,409 161,898 Aug 08 04:16 PM Green Eric Mark Officer Aug 06 '24 Proposed Sale 304.71 30,732 9,364,409 Aug 06 04:47 PM Abraham Silji SVP, Chief Technology Officer Jun 12 '24 Sale 330.78 1,800 595,404 2,860 Jun 13 04:46 PM Green Eric Mark President, CEO and Board Chair May 07 '24 Option Exercise 58.89 75,000 4,416,500 218,908 May 09 03:38 PM Green Eric Mark President, CEO and Board Chair May 07 '24 Sale 366.65 66,000 24,199,050 152,908 May 09 03:38 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
